Form 4: Chimerix CFO Michelle LaSpaluto Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Michelle LaSpaluto, CFO of Chimerix, Inc., sold 1,015 shares of common stock on January 30, 2025, to cover tax liabilities incurred from vesting restricted stock units.
Summary
- On January 30, 2025, Michelle LaSpaluto, the Chief Financial Officer of Chimerix, Inc. (CMRX), sold 1,015 shares of the company's common stock.
- The sale was executed at a price of $4.11 per share.
- This transaction was conducted to cover the tax liability resulting from the vesting of restricted stock units granted on January 17, 2023.
- The sale was made under an automatic sell-to-cover arrangement pursuant to Rule 10b5-1.
- Following the transaction, LaSpaluto directly owns 175,237 shares of Chimerix common stock.
Sentiment
Score: 5
Explanation: Neutral. This is a routine transaction related to tax obligations and doesn't necessarily reflect a positive or negative outlook on the company.
Industry Context
This is a routine transaction related to executive compensation and tax obligations. It is common for executives to sell shares to cover taxes when restricted stock units vest. The use of a 10b5-1 plan suggests the sale was pre-planned and not based on current market information.
Stakeholder Impact
- The sale of shares by an executive could be perceived negatively by some shareholders, but the pre-planned nature of the sale mitigates this concern.
Key Dates
| Date | Description |
|---|---|
| 01/17/2023 | Date of grant for the restricted stock unit award. |
| 01/30/2025 | Date of the stock sale transaction. |
| 01/31/2025 | Date of the signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.